Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TELO

Telomir Pharmaceuticals (TELO)

Telomir Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TELO
DateTimeSourceHeadlineSymbolCompany
06/17/20244:10PMGlobeNewswire Inc.Telomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting PanelNASDAQ:TELOTelomir Pharmaceuticals Inc
05/30/20248:30AMGlobeNewswire Inc.Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1NASDAQ:TELOTelomir Pharmaceuticals Inc
05/24/20249:30AMGlobeNewswire Inc.New to The Street TV Announces Episode 575 with its Four Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV, Saturday, May 25, 2024, at 6:30 PM ETNASDAQ:TELOTelomir Pharmaceuticals Inc
05/16/20249:30AMGlobeNewswire Inc.Telomir Pharmaceuticals, Inc. Signs Media Deal with New to The Street for Network Interview Broadcasts, Billboards, and TV Commercial SupportNASDAQ:TELOTelomir Pharmaceuticals Inc
05/13/20244:31PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TELOTelomir Pharmaceuticals Inc
04/16/20248:30AMGlobeNewswire Inc.Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.NASDAQ:TELOTelomir Pharmaceuticals Inc
04/02/20248:30AMGlobeNewswire Inc.Telomir Pharmaceuticals’ Anti-Aging Expert and NYT Bestselling Author Michael F. Roizen, MD, to Present Promising Pre-Clinical Data for Age-Reversal Drug Telomir-1 at the National Press Club in Washington, DC, on April 15, 2024NASDAQ:TELOTelomir Pharmaceuticals Inc
03/29/20244:44PMGlobeNewswire Inc.UPDATE – Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in CaninesNASDAQ:TELOTelomir Pharmaceuticals Inc
03/26/20248:30AMGlobeNewswire Inc.Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in CaninesNASDAQ:TELOTelomir Pharmaceuticals Inc
03/22/20248:30AMGlobeNewswire Inc.Telomir Pharmaceuticals Releases New Pre-Clinical Data for Telomir-1 to Be Presented at the Global Longevity Federation Conference in Las Vegas on March 26thNASDAQ:TELOTelomir Pharmaceuticals Inc
03/14/20248:30AMGlobeNewswire Inc.Telomir Pharmaceuticals Uses AI Testing Models to Show its Lead Product Candidate’s Potential in DNA Age Reversal ScienceNASDAQ:TELOTelomir Pharmaceuticals Inc
03/07/20248:30AMGlobeNewswire Inc.Telomir Pharmaceuticals Presents Promising Pre-Clinical Data For Its Lead Development Product at Singapore ConferenceNASDAQ:TELOTelomir Pharmaceuticals Inc
03/05/20248:30AMGlobeNewswire Inc.Michael F. Roizen, MD to Increase Activities with Telomir Pharmaceuticals as Special Advisor on Age ReversalNASDAQ:TELOTelomir Pharmaceuticals Inc
02/13/20244:05PMGlobeNewswire Inc.Telomir Pharmaceuticals Announces Closing of Initial Public OfferingNASDAQ:TELOTelomir Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TELO